PSA test poor predictor of prostate cancer outcome (Reuters)

Reuters - The results of a recent study
suggest that the initial prostate-specific antigen (PSA) test
and rate of change in PSA levels are poor predictors of
aggressive prostate cancer among patients whose cancer has not
spread and opt for a "watchful waiting" approach.



Source: http://rss.news.yahoo.com